Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jacqueline Bezençon
Altered Hepatobiliary Disposition of Tolvaptan and Selected Tolvaptan Metabolites in a Rodent Model of Polycystic Kidney Disease
Drug Metabolism and Disposition
Pharmacology
Pharmaceutical Science
Related publications
Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease
American Journal of Nephrology
Nephrology
Puk16 - Cost-Effectiveness of Tolvaptan in Canadian Patients With Autosomal Polycystic Kidney Disease: An Adaptation of the Adpkd Outcomes Model
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Hepatocellular Disposition and Transporter Interactions With Tolvaptan and Metabolites in Sandwich-Cultured Human Hepatocytes
Drug Metabolism and Disposition
Pharmacology
Pharmaceutical Science
Acute Pulmonary Thromboembolism Occurring During Treatment With Tolvaptan in a Patient With Autosomal-Dominant Polycystic Kidney Disease
CEN Case Reports
Nephrology
Tolerability of Aquaretic-Related Symptoms Following Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results From TEMPO 3:4
Kidney International Reports
Nephrology
Idiosyncratic Hepatic Toxicity in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patient in Combined Treatment With Tolvaptan and Amoxicillin/Clavulanic Acid: A Case Report
BMC Nephrology
Nephrology
Patient Selection for the Tolvaptan Therapy Among Those With Chronic Kidney Disease and Heart Failure
Therapeutic Apheresis and Dialysis
Hematology
Nephrology
Tolvaptan in the Treatment of Acute Hyponatremia Associated With Acute Kidney Injury
Case Reports in Nephrology
The Effects of Tolvaptan on Patients With Severe Chronic Kidney Disease Complicated by Congestive Heart Failure
Clinical and Experimental Nephrology
Physiology
Nephrology
